Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoNo recent work listed

Sung Eun Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4281-5625; OpenAlex author ID A5100417508. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Novel Regulators of Macropinocytosis-Dependent Growth Revealed by Informer Set Library Screening in Pancreatic Cancer Cells. Last author DOI 10.3390/metabo12090831↗
  2. UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth. Last author DOI 10.1073/pnas.2103592118↗
  3. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Co-author DOI 10.1038/s41467-019-11044-9↗
  4. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. Co-author DOI 10.1371/journal.pone.0020687↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Frank Patrick Mccormick · 3 shared papers, 2019–2022 · strength 0.40
  2. Sang Hoon Kim · 1 shared paper, 2022 · strength 0.16
  3. Andrew L. Wolfe · 1 shared paper, 2021 · strength 0.12
  4. Man‐Tzu Wang · 1 shared paper, 2019 · strength 0.11
  5. Jeremy M. Sharib · 1 shared paper, 2019 · strength 0.11
  6. Eric Andrew Collisson · 1 shared paper, 2019 · strength 0.11
  7. Ivana Peran · 1 shared paper, 2011 · strength 0.03
  8. Joseph J. LaConti · 1 shared paper, 2011 · strength 0.03
  9. Anton Wellstein · 1 shared paper, 2011 · strength 0.03
  10. John Lindsay Marshall · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.